Although no studies have demonstrated the clinical and prognostic significance of the different BCR/ABL1 transcripts in B-ALL, it has been demonstrated in CML patients [36]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.